Login to Your Account



Lion's pride: Shares soar with appointment of new CEO and $100M equity financing

By Michael Fitzhugh
Staff Writer

Friday, June 3, 2016

Shares of Lion Biotechnologies Inc. climbed 43.4 percent Friday as the cancer immunotherapy developer announced the appointment of new President and CEO Maria Fardis and a $100 million equity financing.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription